| |
|
|
|
|
|
|
|||
|
Blood, 15 January 2008, Vol. 111, No. 2, pp. 482-483.
Megakaryocyte and platelet biology: getting your FAKs straightBRIGHAM AND WOMEN'S HOSPITAL
In this issue of Blood, Hitchcock and colleagues show that the nonreceptor tyrosine kinase FAK plays a critical role in regulating megakaryocyte maturation and platelet function in vivo.
In this issue of Blood, Hitchcock and colleagues report on the generation and characterization of a megakaryocyte lineage-specific FAK knockout mouse that was generated by crossing conditional FAK-floxed mice with the recently described megakaryocyte-lineage specific platelet factor 4 (Pf4)–Cre mouse.4 In a series of elegant experiments, the authors show that FAK plays a central role in megakaryocyte development and platelet biology. The authors begin by showing that specific ablation of FAK from the megakaryocyte lineage results in a significant increase in platelet numbers, increased megakaryocyte progenitor numbers, as well as increased bone marrow megakaryocyte numbers and ploidy. The authors also observed that the thrombopoietin-mediated activation of Lyn kinase, which functions as a negative regulator of megakaryocyte development, is severely attenuated in FAK-null megakaryocytes. The strongest conclusion from their work is that FAK functions as a negative regulator of megakaryopoiesis. These findings suggest that manipulation of FAK may provide a way to increase platelet levels in patients with thrombocytopenia or decrease platelet levels in patients with thrombocytosis. While the majority of this study focused on the function of FAK in megakaryopoiesis, there were also some insights into the role of FAK in platelets. When challenged by localized vascular damage, platelets are rapidly activated to prevent vascular leakage. Platelet activation requires rapid structural changes that remodel the cell cytoskeleton. The other novel finding presented in the article is that FAK–/– platelets display significantly impaired spreading on fibrinogen-coated surfaces when incubated with multiple platelet-agonists. Surprisingly, the impaired spreading was not due to loss of vinculin-rich focal adhesions, suggesting that one of the major roles of FAK in platelets may be reorganization of the cytoskeleton. While many aspects of FAK function remain to be explored, additional studies with megakaryocyte lineage-specific FAK knockout mice are likely to reveal new therapeutic targets that regulate platelet numbers and function.
Footnotes
Conflict-of-interest disclosure: The author declares no competing financial interests.
REFERENCES
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||